Isolated Adrenocorticotropic Hormone Deficiency Caused by Nivolumab in a Patient with Metastatic Lung Cancer

Nivolumab has promising efficacy for treating various advanced malignant tumors, although it has been reported to induce a wide range of autoimmune adverse effects. We herein report the case of a patient with metastatic lung adenocarcinoma who developed adrenal insufficiency after 12 cycles of nivol...

Descripción completa

Detalles Bibliográficos
Autores principales: Takaya, Kazuhiko, Sonoda, Miwa, Fuchigami, Ayako, Hiyoshi, Toru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643175/
https://www.ncbi.nlm.nih.gov/pubmed/28824067
http://dx.doi.org/10.2169/internalmedicine.8548-16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5643175/
https://www.ncbi.nlm.nih.gov/pubmed/28824067
http://dx.doi.org/10.2169/internalmedicine.8548-16

Ejemplares similares